By Charlotte Schubert

Last fall, as the H1N1 ‘swine flu’ pandemic reached full swing, Gordon Bernard of Vanderbilt University Medical Center in Nashville, Tennessee started gearing up to test his idea that statins, which can dampen inflammation, might combat the disease. Whereas clinical trials often take years to get up and running, Bernard’s study was approved in record time—two months. (Click here to continue reading)